Pharma BD Deal Intelligence
Johnson & Johnson / Abiomed Inc.
2022 · Acquisition/Merger · $16.6B · Complete
Announcement Sentiment
88
Strongly positive
Outcome Score
74
Largely worked — most objectives met.
J&J acquired Abiomed for $16.6B for cardiovascular medical technology.
Key facts
- Announced Nov 01, 2022
- Closed Dec 22, 2022
- Deal value $16.6B
- Deal type Acquisition/Merger
- Therapeutic area Cardiovascular
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals